Invention Grant
- Patent Title: Methods for quantifying IL-33
-
Application No.: US17046200Application Date: 2019-04-10
-
Publication No.: US12092634B2Publication Date: 2024-09-17
- Inventor: Michael Partridge , Giane Oliveira Sumner , Joshua Zylstra
- Applicant: Regeneron Pharmaceuticals, Inc.
- Applicant Address: US NY Tarrytown
- Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee Address: US NY Tarrytown
- Agency: McCarter & English, LLP
- Agent John P. Isacson; Alexa Marie J. Derkasch
- International Application: PCT/US2019/026699 2019.04.10
- International Announcement: WO2019/199910A 2019.10.17
- Date entered country: 2020-10-08
- Main IPC: G01N33/53
- IPC: G01N33/53 ; G01N33/68

Abstract:
Methods and compositions for detecting and quantifying cytokines are provided. The disclosed assays have reduced assay interference relative to commercially available assays and/or a control assay. The interference can be cytokine dependent, cytokine independent, or both. One embodiment provides an IL-33 immunoassay that reduces assay interference caused by endogenous soluble IL-33 binding molecules present in the sample. Exemplary soluble IL-33 binding molecules include, but are not limited to anti-IL-33 antibodies, soluble ST2 receptor, and serum components. In some embodiments a blocking agent is added to the sample to reduce, inhibit, or block IL-33 complexes in the sample from reforming after acid dissociation of the IL-33 complexes in the sample. In one embodiment, the blocking agent and the detection reagent do not compete for binding to IL-33.
Public/Granted literature
- US20210033600A1 Methods for Quantifying IL-33 Public/Granted day:2021-02-04
Information query
IPC分类: